Cytokines represent a diverse group of molecules that collectively exert a wide range of actions (1). The term cytokine is rather general, technically referring to a molecule made by one cell that acts on another, but cytokines are primarily growth factors and hormones of the immune and hematopoietic systems. The term broadly encompasses many of the interleukins and colony stimulating factors (which are also referred to as type I cytokines) and interferons (which sometimes are referred to as type II cytokines) (1). Certain molecules, such erythropoietin, thrombopoietin, growth hormone, and prolactin, while not classically thought of as typical cytokines, have similar structures and signaling mechanisms to type I cytokines (1).
Ozaki and Leonard 4 (4) . The basic model is that growth hormone binds first to one monomer via a high affinity ''Site 1'' and then the second receptor monomer interacts with this complex, contacting growth hormone via ''Site 2''. In the case of the growth hormone system, the complex is further stabilized via a receptor-receptor interaction site denoted as "Site 3" (4) . Although this represent a homodimeric receptor system, it is easy to envision how receptor heterodimers would form if the second growth hormone receptor monomer were a distinctive receptor component. Such a second component is represented for example by the common cytokine receptor β chain (β c ), gp130, and the common cytokine receptor γ chain (γ c ), which are discussed below. IL-3, IL-5, and GM-CSF are hematopoietic cytokines, with IL-3 having actions as a ''multi-CSF" on multiple lineages, IL-5 being essential for eosinophil expansion, and GM-CSF acting mainly on granulocytes and macrophages/monocytes. Each of these cytokines has a distinctive α chain (IL-3Rα, IL-5Rα, and GM-CSFRα) but they all share a common β chain, β c , in both humans and mice (5-7, reviewed in 8). Interestingly, in mice but not in humans, there is an IL-3-specific β chain as well, denoted β IL-3 (8, 9) .
IL-3, IL-5, and GM-CSF
Despite the presumed importance of IL-3, IL-5, and GM-CSF for hematopoiesis, disruption of β c in a murine knockout model does not cause a severe defect within the hematopoietic system, although signaling in response to IL-5 and GM-CSF are by guest on http://www.jbc.org/ Downloaded from disrupted and these mice exhibit alveolar proteinosis and defective eosinophil responses (10, 11) . As expected, signaling in response to IL-3 remains normal due to the present of β IL-3 , with IL-3 signaling being eliminated only in the context of β c /IL-3 double knockout mice (12) .
IL-6, IL-11, LIF, Oncostatin M, CNTF, NNT-1/BSF-3, and cardiotrophin-1 share gp130 IL-6, IL-11, LIF, OSM, CNTF, NNT-1/BSF-3, and CT-1 are seven cytokines, some of which were discovered in very different assay systems. Collectively, these cytokines exert multiple actions ranging from the immune system to the cardiovascular system to the central nervous system, but all of them share the gp130 signal transducing molecule as a component of their receptors (13) (14) (15) (16) . IL-6 was originally identified as a B-cell differentiation factor, but it also can exert effects related to T-cell growth, and on many other cell types as well, including the induction of acute phase proteins. IL-11 is a stromal factor that can induce acute phase proteins and has a number of hematopoietic related effects as well, cooperating with IL-3 and stem cell factor. LIF can suppress the differentiation of pluripotent stem cells, inhibit monocyte differentiation of M1 cells, and inhibit adipogenesis, as well as exerting effects in the central nervous system. LIF is identical to cholinergic neural differentiation factor. OSM was originally identified based on its ability to inhibit to growth of a melanoma cell line but it is also a growth potentiator, for example for Kaposi's sarcoma. CNTF is primarily known for its ability to promote neuronal survival. NNT-1/BSF-3 also support survival of chicken embryo motor and sympathetic neurons whereas in mice it potentiates effects of IL-1 and IL-6 and has B-cell stimulating capability. Finally, although CT-1 was discovered based on its actions on cardiac muscle cells, it has a wide range of multi-functional roles, including actions with the hematopoietic and neural systems as well. Thus, a number of these factors have overlapping actions, but they are also distinctive. As noted above, these cytokines all share the gp130 signal transducing molecule (13) (14) (15) (16) Thus, IL-6 and IL-11 do not use LIFRβ, whereas LIF, OSM, CNTF, NNT-1/BSF-3, and CT-1 do. As noted, human OSM can signal through two types of receptors, one of which uses LIFRβ and one of which does not. As part of an investigation of IL-6 signaling, the gene encoding gp130 was disrupted in mice. Unexpectedly, in addition to certain defects in hematopoiesis, targeting of gp130 resulted in a fetal-lethal phenotype due to defect in myocardial development (18) . This phenotype presumably does not relate to a defect in IL-6 signaling but instead may relate to other cytokines such as CT-1. LIFRβ gene disruption results in a neural defect (19, 20) .
IL-12 and IL-23 share IL-2Rβ1.
IL-12 is structurally an interesting cytokine that consists of an IL-6-like cytokine, p35, that associates with p40, a protein that resembles a soluble cytokine receptor. The 13Rα1 but which appears to be a non-functional inhibitory "decoy" receptor (51, 52).
Both IL-4 and IL-13 appear to be important for Th2 differentiation as Il13 -/-mice also show a Th2 differentiation defect (53) . As expected, disruption of the Il4ra gene in mice results in defective Th2 differentiation (54) . In addition to its contribution to Th2 differentiation, IL-13 is essential for worm expulsion and for antigen-induced asthma (55) (56) (57) .
IL-7 and TSLP and the sharing of IL-7Rα
Thymic stromal lymphopoietin (TSLP) was identified as a factor that was present in the medium of a thymic stromal cell line, Z210R.1 and was capable of supporting the growth of a pre-B cell line, NAG8/7 (58). Interestingly, the receptor for TSLP contains its own distinctive receptor chain, TSLPR, as well as IL-7Rα (59, 60). Thus, TSLP and IL-7 share IL-7Rα as a common receptor component ( Figure 1C ). This helps to explain why the phenotype of Il7r -/-mice is somewhat more severe than that seen in Il7 -/-mice, because the former inactivates signaling in response to both IL-7 and TSLP and the latter only signaling in response to IL-7. Interestingly, IL-13Rα1, which can substitute for γ c in the context of IL4 signaling, and TSLPR, which ''replaces'' γ c as one transitions from IL-7 to TSLP signaling both are similar to γ c . This is particularly true of TSLPR, which is the protein in public databases with highest amino acid similarity to γ c (59).
TSLPR was cloned by four groups (59-62). Two groups reported the gene as one that encodes an orphan receptor (61, 62) . In a third case, it was identified initially as an Table 2 .
Conclusions
Type I and type II cytokines exhibit both cytokine pleiotropy and redundancy.
There are now multiple cases wherein the receptors for these cytokines share receptor set of type II cytokines. As additional data emerges on the three-dimensional structure of various cytokine-receptor complexes, a greater understanding of these systems will emerge. This should clarify the specific structural basis for the ability of cytokines to interact with more than one receptor and the ability of a receptor chain to interact with multiple cytokines. 
